AzTrials
AzTrials

Parkinson's DiseaseNCT07403539

Speech Learning and Speech Production in Parkinson's Disease

A study testing Intensity learning, Intensity discrimination and Rate learning in people with Parkinson's Disease, run by State University of New York at Buffalo at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. Read more about this study

Who is it for?
Ages 45 years and older
Conditions the study is for
Parkinson's Disease
What is being tested?
Intensity learning, Intensity discrimination and Rate learning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
27 Jan 2026to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of Parkinson's disease
  • Native speaker of North American English
  • Use a drug that includes levodopa
  • Resident of the United States

Who cannot join

  • Any history of language, hearing or speech disorder outside of Parkinson's disease
  • Other gross neurological impairment such as Alzheimer's disease or stroke
  • Significant hearing loss and/or use of a hearing aid or cochlear implant

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • State University of New York at Buffalo

    Buffalo, New York, 14214

    Mishaela DiNino, Ph.D., 1 (716) 829-5311, dinino@buffalo.edu

    Recruiting

Other trials in United States

About this study

Official title: Relationship Between Speech Perceptual Learning and Speech Production in Parkinson's Disease

Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. By linking these two abilities in individuals with Parkinson's disease using a precision medicine approach, this project seeks to build a basis for new therapies that help people with Parkinson's disease both understand better and speak more clearly.

Read the detailed description

In the context of speech-language therapy, Parkinson's disease (PD) is typically associated with its consequences on speech production. Interventions generally focus on learning or relearning skills to accomplish successful production. However, the disease itself, as well as patient responses to interventions, are variable. Individuals differ widely in how typical their speech output is before intervention and in how much they learn from treatment. One plausible explanation for this variation comes from a less-studied aspect of speech and language in PD: speech perception, especially speech perceptual learning. There is a key gap in the PD literature about whether people who produce atypical rate and intensity properties in their own speech also find it more difficult to learn rate and intensity properties from others' speech. There is, therefore, a critical need for a full understanding of the relationship between speech production and speech perceptual learning in PD. The long- term goal of this research program is to systematically interrogate the relationship between speech learning and production in people with PD and to leverage that knowledge to promote effective communication. The overall objective of this project is to use acoustic measures to determine how challenges with speech perception or learning can predict individual differences in speech production. The central hypothesis is that individual differences between people with PD in speech perception or learning can predict individual differences between people with PD in speech production. This project adopts an individual differences approach to investigate two major aims: (1) relating individual differences in the perceptual learning of speech rate to the production of speech rate, and (2) relating individual differences in the perceptual learning of intensity to the production of intensity. To investigate these aims, each participant will record a speech sample and conduct tasks that involve learning regularities in rate or intensity in the speech of others. Participants will also complete tasks that require the ability to distinguish between sentences based on their rate and intensity. Participants' speech samples will additionally be judged by naive listeners to assess the samples' intelligibility and the effort that it takes to understand the speakers. If individual differences in perceptual learning predict individual differences in production, then differences in speech perception may predict differences in speech-language therapy outcomes that could be targeted to patient needs. A precision medicine approach would allow for interventions that titrate the amount, level, and type of intervention on an individualized basis to make sure that treatments are focused on participants who will respond to them in dosages that they will benefit from. For instance, a therapist could provide speech perception training to accelerate outcomes of production-related treatments. Furthermore, by applying more naturalistic measures of speech perception to this population, especially ones that rely on participants to change over the course of a session, this project provides an innovative opportunity to examine the sensory and perceptual consequences of PD and to link those to better-documented motor outcomes

Being tested
Intensity learning, Intensity discrimination, Rate learning, Rate discrimination
Keywords
speech perception, communication, learning
Medical subject headings
Parkinson Disease, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensity learningBehavioural

    Participants will be asked to pair sentences that vary in their sound intensity to one of three colored squares (red, yellow, or blue)

  • Intensity discriminationBehavioural

    Participants will hear two sentences that are either the same or different in their sound intensity and will be asked to indicate whether the sentences were of the same or different intensities

  • Rate learningBehavioural

    Participants will be asked to pair sentences that vary in their spoken rate to one of three colored squares (red, yellow, or blue)

  • Rate discriminationBehavioural

    Participants will hear two sentences that are either the same or different in their spoken rate and will be asked to indicate whether the sentences were of the same or different rates

Study groups in NCT07403539
Study groupRoleWhat they receive
Learning and DiscriminationExperimentalBehavioral interventions will be administered, including speech intensity learning, speech intensity discrimination, speech rate learning, and speech rate discrimination
Receives: Behavioral: Intensity learning; Behavioral: Intensity discrimination; Behavioral: Rate learning; Behavioral: Rate discrimination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean dB SPL

    The mean speech intensity (in dB SPL) will be assessed using a recording of spoken sentences and a spoken paragraph.

    Measured: Day 1

  2. Standard deviation dB SPL

    The standard deviation of participant's speech intensity (in dB SPL) will be assessed using a recording of spoken sentences and a spoken paragraph.

    Measured: Day 1

  3. Speaking rate

    The speaking rate (in syllables/second) will be assessed using a recording of spoken sentences and a spoken paragraph.

    Measured: Day 1

  4. Articulation rate

    The articulation rate (in syllables/second after removing pauses) will be assessed using a recording of spoken sentences and a spoken paragraph.

    Measured: Day 1

  5. Unfilled pause time

    The unfilled pause time (in seconds of pause) will be assessed using a recording of spoken sentences and a spoken paragraph.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2026
  2. Study start27 Jan 2026
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07403539
Sponsor's protocol ID
STUDY00008661
Status last verified
Sep 2026
First submitted
27 Jan 2026
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified speech perception and speech production data from individual participants

Questions about this trial

What is this clinical trial studying?

A study testing Intensity learning, Intensity discrimination and Rate learning in people with Parkinson's Disease, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean dB SPL (time frame: Day 1). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in